Journal article

The host microbiome and impact of tuberculosis chemotherapy.

Ronan F O'Toole, Sanjay S Gautam

Tuberculosis (Edinb) | Published : 2018

Abstract

The treatment of Mycobacterium tuberculosis infection is often viewed in isolation from other human microbial symbionts. Understandably, the clinical priority is eliminating active or latent tuberculosis (TB) in patients. With the increasing resolution of molecular biology technologies, it is becoming apparent that antibiotic treatment can perturb the homeostasis of the host microbiome. For example, dysbiosis of the gut microbiota has been associated with an increased risk of the development of asthma, obesity and diabetes. Therefore, fundamental questions include: Does TB chemotherapy cause disruption of the human microbiome and adverse effects in patients; and are there signature taxa of d..

View full abstract

University of Melbourne Researchers